Literature DB >> 9070144

Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia.

F Lyall1, I A Greer, F Boswell, R Fleming.   

Abstract

OBJECTIVE: To determine whether vascular endothelial growth factor (VEGF) concentrations are altered in pre-eclampsia.
DESIGN: Serum was prepared from peripheral venous blood and stored at -70 degrees C. Serum VEGF concentrations were measured by ELISA.
SETTING: University of Glasgow Department of Obstetrics and Gynaecology, Royal Infirmary, Glasgow. PARTICIPANTS: Twenty-two healthy nonpregnant volunteer women, 34 normal pregnant women and 34 women with pre-eclampsia were studied.
RESULTS: Serum concentrations of VEGF were significantly lower in normal pregnant women (median value 12.89 pg/mL) than in nonpregnant women (median value 166 pg/mL; P < 0.0001). In pre-eclampsia VEGF concentrations were significantly lower (median value 2.34 pg/mL) than normal pregnancies (P < 0.0001). Postpartum concentrations of VEGF in the group complicated by pre-eclampsia (median value 76.42 pg/mL) were not significantly different from nonpregnant values (P = 0.2).
CONCLUSIONS: Our results show that serum concentrations of VEGF are suppressed in pregnancy and further reduced in pre-eclampsia. Further studies to elucidate the mechanisms which lead to a reduction in VEGF concentrations may provide new clues to the aetiology of this disorder.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9070144     DOI: 10.1111/j.1471-0528.1997.tb11050.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  31 in total

Review 1.  Preeclampsia, an implantation disorder.

Authors:  Leslie L Waite; Amy K Atwood; Robert N Taylor
Journal:  Rev Endocr Metab Disord       Date:  2002-05       Impact factor: 6.514

2.  Endothelial-derived hyperpolarization factor (EDHF) contributes to PlGF-induced dilation of mesenteric resistance arteries from pregnant rats.

Authors:  Maurizio Mandalà; Natalia Gokina; Carolyn Barron; George Osol
Journal:  J Vasc Res       Date:  2011-10-06       Impact factor: 1.934

3.  Microbial invasion of the amniotic cavity in preeclampsia as assessed by cultivation and sequence-based methods.

Authors:  Daniel B DiGiulio; Mariateresa Gervasi; Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Kimberley S Seok; Ricardo Gómez; Pooja Mittal; Francesca Gotsch; Tinnakorn Chaiworapongsa; Enrique Oyarzún; Chong Jai Kim; David A Relman
Journal:  J Perinat Med       Date:  2010-09       Impact factor: 1.901

4.  Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products.

Authors:  Eleazar Soto; Roberto Romero; Karina Richani; Jimmy Espinoza; Tinnakorn Chaiworapongsa; Jyh Kae Nien; Sam S Edwin; Yeon Mee Kim; Joon Seok Hong; Luis F Goncalves; Lami Yeo; Moshe Mazor; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Matern Fetal Neonatal Med       Date:  2010-07

5.  A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Edi Vaisbuch; Shali Mazaki-Tovi; Francesca Gotsch; Samuel S Edwin; Ricardo Gomez; Lami Yeo; Agustin Conde-Agudelo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2009-11

6.  Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death.

Authors:  Amy E Whitten; Roberto Romero; Steven J Korzeniewski; Adi L Tarca; Alyse G Schwartz; Lami Yeo; Zhong Dong; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

7.  Retinol binding protein 4--a novel association with early-onset preeclampsia.

Authors:  Edi Vaisbuch; Roberto Romero; Shali Mazaki-Tovi; Offer Erez; Sun Kwon Kim; Tinnakorn Chaiworapongsa; Francesca Gotsch; Nandor Gabor Than; Zhong Dong; Percy Pacora; Ronald Lamont; Lami Yeo; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

8.  First-trimester maternal serum PP13 in the risk assessment for preeclampsia.

Authors:  Roberto Romero; Juan Pedro Kusanovic; Nandor Gabor Than; Offer Erez; Francesca Gotsch; Jimmy Espinoza; Samuel Edwin; Ilana Chefetz; Ricardo Gomez; Jyh Kae Nien; Marei Sammar; Beth Pineles; Sonia S Hassan; Hamutal Meiri; Yossi Tal; Ido Kuhnreich; Zoltan Papp; Howard S Cuckle
Journal:  Am J Obstet Gynecol       Date:  2008-06-09       Impact factor: 8.661

9.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

10.  The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

Authors:  Offer Erez; Roberto Romero; Jimmy Espinoza; Wenjiang Fu; David Todem; Juan Pedro Kusanovic; Francesca Gotsch; Samuel Edwin; Jyh Kae Nien; Tinnakorn Chaiworapongsa; Pooja Mittal; Shali Mazaki-Tovi; Nandor Gabor Than; Ricardo Gomez; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.